HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Dr.
HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA).
Dr. Reddy’s doxycycline capsules, 40 mg, are supplied in bottle counts of 30.
Please click here to see the full prescribing information – https://www.drreddys.com/pil/doxycycline-capsules.pdf.
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
Seasonal shoppers focus on deals to make the most of every festive dollar this season.
The partnership will focus on supporting family caregivers with loved ones managing incontinence.
Nature’s Truth also remains the top brand in the independent pharmacy subcategories of single-letter vitamins; herbals and botanicals; specialty supplements; and mineral supplements, increasing its share in all four.
Chain Drug Review and Kearney hosted their third annual Health Equity Summit in Chicago, where a panel of experts discussed the prevalence of pharmacy deserts, affecting millions of Americans, and strategies to address these disparities.
